18F-FDG PET-CT联合多项肿瘤标志物对胃癌术后转移或复发的监测价值
摘要
关键词
全文:
PDF参考
Strand M S, Lockhart A C, Fields R C. Genetics of Gastric Cancer[J]. Surgical Clinics of North America,2017,97(2):345-370.
Wang T, Cai H, Sasazuki S, et al. Fruit and Vegetable Consumption, Helicobacter Pylori Antibodies, and Gastric Cancer Risk: A Pooled Analysis of Prospective Studies in China, Japan, and Korea[J]. International Journal of Cancer, 2017(17):25-36.
Lu J, Wang W, Zheng C H, et al. Influence of Total Lymph Node Count on Staging and Survival after Gastrectomy for Gastric Cancer: An Analysis From a Two-institution Database in China[J]. Annals of Surgical Oncology,2017,24(2):486-493.
徐晓辉,何涛,王欢.18F-FDG PET/CT在胃癌术后复发及转移监测中的应用[J].中国CT和MRI杂志,2021,19(10):152-154.
李光军.18F-FDG PET-CT在胃癌诊断、疗效评价及转移复发监测中的临床应用价值研究[J].中国实用医药,2020,15(16):54-56.
张丰坤,周伟娜,张国建,等.18F-FDG PET/CT与血清CEA对进展期胃癌新辅助化疗联合手术治疗后转移或复发监测价值[J].国际检验医学杂志,2017(17):2383-2385.
DOI: https://doi.org/10.12346/pmr.v4i1.5428
Refbacks
- 当前没有refback。